Laboratory:Hachioji

Laboratory:Hachioji
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
Prealbumin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Turbidimetric immunoassay(TIA) Turbidimetric immunoassay (TIA) |
22.0-40.0 (mg/dL) |
α1-Microglobulin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 | Latex agglutination immunoassay |
Male: 12.5-25.5 Female: 11.0- 19.0 (mg/L) |
α1-Microglobulin
|
random urine
0.5 |
U00 |
![]() |
2-4 | Latex agglutination immunoassay |
Male: 1.0-15.5 Female: 0.5-9.5 (mg/L) |
|
α1-Antitrypsin
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Nephelometry Nephelometry |
94-150 (mg/dL) |
α1-acidglycoprotein
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Nephelometry Nephelometry |
Male: 45-98 Female: 39-86 (mg/dL) |
Retinol binding protein (RBP)
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Latex agglutination immunoassay Latex agglutination immunoassay (LA) |
Male: 2.7-6.0 Female: 1.9-4.6 (mg/dL) |
α2-macroglobulin
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Nephelometry Nephelometry |
Male: 100-200 Female: 130-250 (mg/dL) |
Haptoglobin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Nephelometry Nephelometry |
Type 1-1: 83- 209 Type 2-1: 66- 218 Type 2-2: 25- 176 (mg/dL) |
Ceruloplasmin
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Nephelometry Nephelometry |
21-37 (mg/dL) |
Transferrin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Turbidimetric immunoassay(TIA) Turbidimetric immunoassay (TIA) |
Male: 190-300 Female: 200-340 (mg/dL) |
Transferrin, Urine
|
urine collected for 24 hrs
0.5 |
U00 |
![]() (1 month) |
2-4 |
Latex agglutination immunoassay Latex agglutination immunoassay (LA) |
≦ 0.80 (mg/day) |
|
Transferrin, Urine (creatinine ratio)
|
random urine
1 |
U00 |
![]() (1 month) |
2-4 |
Latex agglutination immunoassay Latex agglutination immunoassay (LA) |
Transferrin, Urine adjustment ≦ 1.00 (mg/g CRE) |
|
β2-microglobulin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 | Latex agglutination immunoassay |
1.0-1.9 (mg/L) |
β2-microglobulin
|
urine collected for 24 hrs
0.5 |
U00 |
![]() |
2-4 | Latex agglutination immunoassay |
≦ 230 (μg/L) |
|
β2-microglobulin
|
random urine
0.5 |
U00 |
![]() |
2-4 | Latex agglutination immunoassay |
≦ 230 (μg/L) |
|
C-reactive protein (CRP) quantitative
|
serum
0.6 |
S09 ↓ A00 |
![]() |
![]() |
2-4 | Latex turbidimetric immunoassay |
≦ 0.30 (mg/dL) |
Pentraxin 3 (PTX3)
|
![]() plasma 0.3 |
PN2,PN5 ↓ A00 |
![]() |
![]() |
3-9 |
ELISA Enzyme-linked immunosorbent assay (ELISA) |
0.73-5.49(ng/mL) |
Amyloid A protein, Serum (SAA)
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() (28 days) |
2-4 | Latex agglutination immunoassay |
≦ 8.0 (μg/mL) |
Myoglobin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
CLIA Chemiluminescent immunoassay (CLIA) |
Male: ≦ 154.9 Female: ≦ 106.0 (ng/mL) |
Human heart type fatty acid-binding protein (H-FABP)
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() (28 days) |
2-4 | Latex agglutination method |
< 6.2 (ng/mL) |
Ventricle myosin light chain I
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-5 |
EIA Enzyme immunoassay (EIA) |
≦ 2.5 (ng/mL) |
Myocardial troponin T
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() (14 days) |
2-4 |
ECLIA Electro chemiluminescence immunoassay (ECLIA) |
≦ 0.014 Cutoff to diagnose acute myocardial infarction 0.100 (ng/mL) |
Ferritin
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
Male: 39.4-340 Female: 3.6-114 (ng/mL) |
L fatty acid binding protein (L-FABP), CLEIA
|
random urine
2.0 |
U00 |
![]() (14 days) |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
L-FABP creatinine ratio: ≦ 8.4 (μg/gCr) |
|
Urine NGAL
|
random urine
2.0 |
↓ U00 |
![]() (7 days) |
2-4 |
CLIA Chemiluminescent immunoassay (CLIA) |
≦ 30.5 (ng/mL) Creatinine ratio: ≦ 21.7 (μg/gCr) |
|
Human oncofetal fibronectin
|
vaginal secretion
|
VP5 |
![]() (1 month) |
2-4 |
ELISA Enzyme-linked immunosorbent assay (ELISA) |
Negative | |
Procollagen type I N-propeptide (total P1NP)
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() (28 days) |
2-4 |
ECLIA Electro chemiluminescence immunoassay (ECLIA) |
Male age 30-83: 18.1-74.1 Premenopausal age 30-44: 16.8-70.1 Postmenopausal age 45-79: 26.4-98.2 (ng/mL) |
Collagen type I cross-linked N-telopeptide (NTx)
|
random urine
3 |
U00 |
![]() |
2-4 |
ELISA Enzyme-linked immunosorbent assay (ELISA) |
See below. | |
Collagen type I cross-linked N-telopeptide (NTx), osteoporos
|
random urine
3 |
U00 |
![]() |
2-4 |
ELISA Enzyme-linked immunosorbent assay (ELISA) |
Male : 13.0-66.2 Premenopausal: 9.3-54.3 Postmenopausal: 14.3-89.0 (Reference) (nmolBCE/mmol CRE) See the following criteria. |
|
Collagen type I, C-terminal telopeptide (ICTP)
|
serum
0.3 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
RIA2 antibody assay Radio immunoassay (RIA) |
< 4.5(ng/mL) |
Mac-2 binding protein glycosylated isomers (M2BPGi)
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
(-) See below. |
Autotaxin
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() (21 days) |
2-4 |
FEIA Fluorescence enzyme immunoassay (FEIA) |
See below. (mg/L) |
Procollagen III peptide (P-III-P), CLIA
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
CLIA Chemiluminescent immunoassay (CLIA) |
3.62-9.52 (ng/mL) |
Collagen type IV
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
Latex agglutination immunoassay Latex agglutination immunoassay (LA) |
≦ 150 (ng/mL) |
Collagen type IV, Urine
|
random urine
5 |
U70 |
![]() (1 month) |
3-9 |
EIA Enzyme immunoassay (EIA) |
30-39 years old ≦ 4.0 ≧ 40 years old ≦ 4.9 (μg/g CRE) |
|
Deoxypyridinoline
|
random urine
3 |
U00 |
![]() |
2-4 |
EIA Enzyme immunoassay (EIA) |
Creatinine adjustment Male: 2.1-5.4 Female: 2.8-7.6 (nmol/mmol CRE) |
|
Deoxypyridinoline (DPD), osteoporosis
|
random urine
3 |
U00 |
![]() |
2-4 |
EIA Enzyme immunoassay (EIA) |
Creatinine ratio Male: 2.1-5.4 Female: 2.8-7.6 (nmol/mmol CRE) See the following criteria. |
|
|
serum
0.2 |
SEC ↓ A00 |
![]() |
![]() |
2-8 |
FEIA Fluorescence enzyme immunoassay (FEIA) |
Adult: ≦ 14.9 (μg/L) |
KL-6
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
< 500 (U/mL) |
Procalcitonin
|
serum
0.4 |
S09 ↓ A00 |
![]() |
![]() (28 days) |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
≦ 0.05 (ng/mL) |
Presepsin
|
![]() serum 0.4 |
S09 ↓ A00 |
![]() |
![]() (28 days) |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
The cutoff value for the diagnosis of sepsis (bacterial): 500 (pg/mL) |
Presepsin
|
![]() plasma 0.4 |
PH5 ↓ A00 |
![]() |
![]() (28 days) |
2-4 |
CLEIA Chemiluminescent enzyme immunoassay (CLEIA) |
The cutoff value for the diagnosis of sepsis (bacterial): 500 (pg/mL) |
|
random urine
6 |
U50 |
![]() |
![]() (21 days) |
2-5 |
RIA2 antibody assay Radio immunoassay (RIA) |
≦ 10 (ng/mL) |
|
serum
0.5 |
S09 ↓ A00 |
![]() |
![]() |
3-5 |
RIA2 antibody assay Radio immunoassay (RIA) |
≦ 6 (ng/mL) |
|
serum
0.6 |
S09 ↓ A00 |
![]() |
![]() (21 days) |
Please contact us in advance. | CDT:Nephelometry Transferrin:Turbidimetric Immunoassay(TIA) |
%CDT 1.24-2.16 Cutoff of alcoholic liver disease: 2.00 (%) Transferrin Male: 190-300 Female: 200-340 (mg/dL) |